{"id":"https://openalex.org/W20987604","doi":null,"title":"Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody","display_name":"Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody","publication_year":2011,"publication_date":"2011-05-01","ids":{"openalex":"https://openalex.org/W20987604","mag":"20987604"},"language":"en","primary_location":{"id":"mag:20987604","doi":null,"is_oa":false,"landing_page_url":"http://jnm.snmjournals.org/content/52/supplement_1/1680.short","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003204402","display_name":"Catharina M. van Rij","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Catharina van Rij","raw_affiliation_strings":["Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089453603","display_name":"Cathelijne Frielink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Cathelijne Frielink","raw_affiliation_strings":["Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043569662","display_name":"Robert M. Sharkey","orcid":"https://orcid.org/0000-0003-1408-0905","observed_orcids":["https://orcid.org/0000-0003-1408-0905"]},"institutions":[{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Sharkey","raw_affiliation_strings":["Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ"],"raw_orcid":"https://orcid.org/0000-0003-1408-0905","affiliations":[{"raw_affiliation_string":"Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ","institution_ids":["https://openalex.org/I4210131484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[{"id":"https://openalex.org/I4210131484","display_name":"Center for Molecular Medicine and Immunology","ror":"https://ror.org/03fhjvs31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210131484"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Goldenberg","raw_affiliation_strings":["Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ","institution_ids":["https://openalex.org/I4210131484"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William J. McBride","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126919","display_name":"Immunomedics (United States)","ror":"https://ror.org/02pf50490","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J. McBride","raw_affiliation_strings":["Immunomedics, Inc., Morris Plains, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomedics, Inc., Morris Plains, NJ","institution_ids":["https://openalex.org/I4210126919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110822733","display_name":"Edmund Rossi","orcid":"https://orcid.org/0000-0002-5861-9434","observed_orcids":["https://orcid.org/0000-0002-5861-9434"]},"institutions":[{"id":"https://openalex.org/I4210104403","display_name":"iCo Therapeutics (Canada)","ror":"https://ror.org/01ge9a191","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210104403"]},{"id":"https://openalex.org/I4210105596","display_name":"Morrison Tech","ror":"https://ror.org/017g1tr52","country_code":"US","type":"education","lineage":["https://openalex.org/I4210105596"]},{"id":"https://openalex.org/I4210109743","display_name":"DAWN Center for Independent Living","ror":"https://ror.org/01dwm7q20","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210109743"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Edmund Rossi","raw_affiliation_strings":["IBC Pharmaceuticals, Inc., Morris Plains, NJ"],"raw_orcid":"https://orcid.org/0000-0002-5861-9434","affiliations":[{"raw_affiliation_string":"IBC Pharmaceuticals, Inc., Morris Plains, NJ","institution_ids":["https://openalex.org/I4210104403","https://openalex.org/I4210105596","https://openalex.org/I4210109743"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109346302","display_name":"Chien\u2010Hsing Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126919","display_name":"Immunomedics (United States)","ror":"https://ror.org/02pf50490","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chien\u2010Hsing Chang","raw_affiliation_strings":["Immunomedics, Inc., Morris Plains, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunomedics, Inc., Morris Plains, NJ","institution_ids":["https://openalex.org/I4210126919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000396669","display_name":"Wim J.G. Oyen","orcid":"https://orcid.org/0000-0001-8235-7078","observed_orcids":["https://orcid.org/0000-0001-8235-7078"]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wim J.G. Oyen","raw_affiliation_strings":["Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands"],"raw_orcid":"https://orcid.org/0000-0001-8235-7078","affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012764804","display_name":"Otto C. Boerman","orcid":"https://orcid.org/0000-0001-6832-101X","observed_orcids":["https://orcid.org/0000-0001-6832-101X"]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"funder","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Otto C. Boerman","raw_affiliation_strings":["Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands","institution_ids":["https://openalex.org/I145872427","https://openalex.org/I2802934949"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00212777,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"52","issue":null,"first_page":"1680","last_page":"1680"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9440000057220459},{"id":"https://openalex.org/keywords/pretargeting","display_name":"pretargeting","score":0.9589999914169312},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9010000228881836},{"id":"https://openalex.org/keywords/internalization","display_name":"internalization","score":0.652999997138977},{"id":"https://openalex.org/keywords/tumor-retention","display_name":"tumor retention","score":0.5630000233650208},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.7149999737739563},{"id":"https://openalex.org/keywords/radiolabeled-antibodies","display_name":"radiolabeled antibodies","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2777836882","wikidata":"https://www.wikidata.org/wiki/Q22907915","display_name":"Pretargeting","level":5,"score":0.9924819469451904},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.9274601936340332},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6326623558998108},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.628294050693512},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5772070288658142},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5689348578453064},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5235823392868042},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.49151095747947693},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.48407068848609924},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4834459722042084},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.474056214094162},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4120227098464966},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36644846200942993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22209852933883667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21945428848266602},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2029602825641632},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.19776004552841187},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17730742692947388},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15308430790901184},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.132451593875885},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:20987604","doi":null,"is_oa":false,"landing_page_url":"http://jnm.snmjournals.org/content/52/supplement_1/1680.short","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8100000023841858,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2032709472","https://openalex.org/W2133860094","https://openalex.org/W2039938791","https://openalex.org/W2163113732","https://openalex.org/W7100000144","https://openalex.org/W2338355774","https://openalex.org/W2099912528","https://openalex.org/W4282971588","https://openalex.org/W2007886847","https://openalex.org/W49918653"],"abstract_inverted_index":{"1680":[0],"Objectives":[2],"The":[4],"monoclonal":[5],"antibody":[6,35],"RS7":[7,111],"(anti-EGP-1)":[8],"effectively":[9],"targets":[10],"prostate":[11,192],"cancer":[12],"(PC),":[13],"and":[14,49,78,80,95,104,112],"because":[15],"it":[16,186],"internalizes,":[17,185],"111In-RS7":[18],"provides":[19],"good":[20],"tumor":[21,163,209],"uptake.":[22],"This":[23],"study":[24],"examined":[25],"the":[26,45,50,61,92,129,162,174,196,200,202,208],"prospects":[27],"for":[28,38,190],"using":[29],"an":[30],"anti-EGP-1":[31],"x":[32],"anti-HSG":[33],"bispecific":[34],"(bsMAb),":[36],"TF12,":[37,52],"pretargeting.":[39],"Methods":[41],"Internalization":[43],"of":[44,65,124,131,173,199],"anti-EGP1":[46],"antibody,":[47,201],"RS7,":[48],"bsMAb,":[51],"by":[53],"PC3":[54,73,138],"cells":[55,139],"was":[56,140,164,187],"determined":[57],"in":[58,60,128,137,155,161,207],"vitro":[59],"presence":[62,130],"or":[63],"absence":[64],"di-HSG":[66],"peptide":[67],"(IMP288).":[68],"Mice":[69],"with":[70,122],"s.c.":[71],"human":[72],"tumors":[74],"were":[75,88],"given":[76,89],"111In-TF12":[77,135],"125I-TF12":[79,144],"necropsied":[81,97],"16":[82],"h":[83,106,169],"later,":[84],"while":[85],"other":[86],"mice":[87],"111In-IMP288":[90,159],"after":[91,170],"TF12":[93,113,184],"injection":[94,171],"then":[96],"at":[98,115,167,176],"1,":[99],"2,":[100],"4,":[101],"24,":[102],"48,":[103],"72":[105],"p.i.":[107],"Results":[109],"internalized":[114],"a":[116],"comparable":[117],"rate":[118],"over":[119],"24":[120],"h,":[121],"evidence":[123],"early":[125],"enhanced":[126],"internalization":[127,152],"IMP288":[132],"(Table":[133],"1).":[134],"uptake":[136,160],"7-fold":[141],"higher":[142],"than":[143],"(4.9\u00b10.6%":[145],"ID/g":[146],"vs.":[147],"0.7\u00b10.2":[148],"%ID/g,":[149],"respectively),":[150],"indicating":[151],"also":[153],"occurs":[154],"vivo.":[156],"Nevertheless,":[157],"TF12-pretargeted":[158],"still":[165],"high":[166],"48":[168],"(50%":[172],"%ID/g":[175],"1":[177],"h).":[178],"Conclusions":[180],"Even":[182],"though":[183],"highly":[188],"effective":[189],"pretargeting":[191],"cancer.":[193],"Due":[194],"to":[195],"internalizing":[197],"properties":[198],"radiolabel":[203],"shows":[204],"excellent":[205],"retention":[206]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}